Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 20Carcinoma, Renal Cell 16Liver Neoplasms 7Leukemia, Myeloid, Acute 3Thyroid Neoplasms 2Financial Stress 2Carcinoma 2Patient Preference 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Kidney Neoplasms 1Colorectal Neoplasms 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Adenoma, Islet Cell 1

Interventions

Surveys and Questionnaires 1Sunitinib 1Sorafenib 1Phlebotomy 1Pancreatectomy 1Histocompatibility Testing 1Gefitinib 1Everolimus 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Blood Specimen Collection 1Biopsy, Large-Core Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Adenoma, Islet Cell × Sorafenib × Clear all
NCT06592989 2025-01-10

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
20 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡